Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. The patches of skin affected become white and usually have sharp margins. The hair from the skin may also become white.
This report contains market size and forecasts of Vitiligo Therapeutics in Global, including the following market information:
Global Vitiligo Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Vitiligo Therapeutics market was valued at 1608.8 million in 2021 and is projected to reach US$ 2003.8 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vitiligo Therapeutics include Bausch Health, Baxter, Bristol-Myers Squibb, Celgene, Astellas Pharma, Aclaris Therapeutics, Puneet Laboratories and Clinuvel Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vitiligo Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vitiligo Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Vitiligo Therapeutics Market Segment Percentages, by Type, 2021 (%)
Topical
Oral
Others
Global Vitiligo Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Vitiligo Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Vitiligo Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Vitiligo Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vitiligo Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Vitiligo Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Baxter
Bristol-Myers Squibb
Celgene
Astellas Pharma
Aclaris Therapeutics
Puneet Laboratories
Clinuvel Pharmaceuticals